Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding ...

With Tuesday’s announcement, Eastern North Carolina adds to its reputation for large-scale pharmaceutical manufacturing, as ...

An OPEC+ panel is unlikely this week to recommend any changes to its current deal to reduce production and to start unwinding ...

Pfizer will receive around £2.7 billion in aggregate from Haleon from an offering and a share buyback.

Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...

Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...

Pfizer anticipates revenue growth, driven by oncology investments, M&A activities, and manufacturing optimization. See why ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Drugs giant struggling to manage slump in demand for Covid vaccines and antivirals as it falls behind rivals on obesity ...

Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

On September 23, Chris Watling, Longview Economics founder, CEO, and chief market strategist, appeared in an interview on ...